HRMY Harmony Biosciences Holdings PE ratio, current and historical analysis
The P/E ratio for Harmony Biosciences Holdings stock stands at 12.78 as of Mar 13, 2025. This takes into account the latest EPS of $2.56 and stock price of $32.72. A decrease of 17% has been observed in the PE ratio compared to its average of 15.4 of the past four quarters.
HRMY PE ratio history
Over the last four years, the average PE ratio of Harmony Biosciences Holdings has been 28.93. The current 12.78 price-to-earnings ratio is 56% less than the historical average. Analyzing the last four years, HRMY's PE ratio reached its highest point in the Mar 2021 quarter at 103.25, with a price of $33.04 and an EPS of $0.32. The Mar 2023 quarter saw the lowest point at 10.24, with a price of $32.65 and an EPS of $3.19.
Harmony Biosciences Holdings PE ratio by year
Maximum annual decrease: -74.74% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 13.44 | -9.68% | $34.41 | $2.56 |
| 2023 | 14.88 | -17.1% | $32.3 | $2.17 |
| 2022 | 17.95 | -74.74% | $55.1 | $3.07 |
| 2021 | 71.07 | N/A | $42.64 | $0.6 |
| 2020 | N/A | N/A | $36.15 | -$2.48 |
| 2019 | N/A | N/A | N/A | -$24.07 |
| 2018 | N/A | N/A | N/A | -$7.91 |
Harmony Biosciences Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 13.44 | -27.74% | $34.41 | $2.56 |
| Sep 2024 | 18.6 | 22.05% | $40 | $2.15 |
| Jun 2024 | 15.24 | 6.65% | $30.17 | $1.98 |
| Mar 2024 | 14.29 | -3.97% | $33.58 | $2.35 |
| Dec 2023 | 14.88 | 14.46% | $32.3 | $2.17 |
| Sep 2023 | 13 | 24.16% | $32.77 | $2.52 |
| Jun 2023 | 10.47 | 2.25% | $35.19 | $3.36 |
| Mar 2023 | 10.24 | -42.95% | $32.65 | $3.19 |
| Dec 2022 | 17.95 | 6.59% | $55.1 | $3.07 |
| Sep 2022 | 16.84 | -66.16% | $44.29 | $2.63 |
| Jun 2022 | 49.77 | -15.08% | $48.77 | $0.98 |
| Mar 2022 | 58.61 | -17.53% | $48.65 | $0.83 |
| Dec 2021 | 71.07 | 248.55% | $42.64 | $0.6 |
| Sep 2021 | 20.39 | 37.96% | $38.33 | $1.88 |
| Jun 2021 | 14.78 | -85.69% | $28.23 | $1.91 |
HRMY average PE ratio chart
The current PE ratio of HRMY is under its 3-year average.
HRMY PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| HRMY Harmony Biosciences Holdings Inc | 12.78 | $1.88B |
| OPTN OptiNose Inc | N/A | $54M |
| OPK Opko Health Inc | N/A | $1.16B |
| ORGO Organogenesis Holdings Inc | N/A | $665.85M |
Frequently asked questions
What is Harmony Biosciences Holdings's PE ratio?
As of Mar 13, 2025, HRMY stock has a price to earnings ratio of 12.78.
What is the 3-year average PE ratio for Harmony Biosciences Holdings (HRMY)?
The 3-year average PE ratio for HRMY stock is 21.11.
What is the highest PE ratio for HRMY?
Over the last four years, the quarterly PE ratio reached its highest level at 103.25 in the Mar 2021 quarter.
How does the current PE ratio for HRMY compare to its historical average?
HRMY's price to earnings ratio is currently 56% below its 4-year historical average.
How is HRMY's PE ratio calculated (Harmony Biosciences Holdings PE ratio formula)?
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Mar 13, 2025), Harmony Biosciences Holdings's share price is $32.72. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $2.56. Therefore, Harmony Biosciences Holdings's price to earnings ratio for today is 12.78. PE RATIO(12.78) = STOCK PRICE($32.72) / TTM EPS($2.56)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.